Pulsed Field Ablation Innovator Argá Medtech Announces €54 Million Oversubscribed Series B Capital Raise
Pulsed Field Ablation Innovator Argá Medtech Announces €54 Million Oversubscribed Series B Capital Raise
02/27/24, 3:31 PM
Location
epalingesMoney raised
€54 million
Industry
manufacturing
medical device
biotechnology
health care
Round Type
series b
Investors
Undisclosed Strategic Investor, Gilde Healthcare (The Netherlands), Earlybird Health (Germany), Advent Life Sciences (Uk)
Argá Medtech announced the closure of a €54M oversubscribed Series B funding. The financing enables Argá Medtech to advance the development of its innovative CSE™ Pulsed Field Ablation (PFA) system for treating AF through the execution of an IDE study in the US and a CE Mark study in the EU.
Company Info
Location
epalinges, vaud, switzerland
Additional Info
Argá Medtech is a private company developing Coherent Sine-Burst Electroporation™ (CSE™), a next-generation cardiac ablation system for treating cardiac arrhythmias, including atrial fibrillation (AF). The company is setting the standard for the next-generation Pulsed Field Ablation (PFA) systems with its versatile catheter design able to create circular, linear, and focal lesions, coupled with a unique CSE™ PFA waveform that allows energy titration based on tissue depth to achieve durable lesions.